Enhancing targeted therapy of tumors with activating FGFR alterations. This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I. This abstract does not include a full text component.
A drug that could halt the progression of multiple sclerosis may soon be developed thanks to a discovery by a team at the CHUM Research Centre and the University of Montreal. The researchers have ...
Researchers at SAHMRI and the University of Adelaide have pinpointed a tumor support signal that works to suppress the immune system. Blocking this signal may prove pivotal in stopping bowel cancer.
A pilot feasibility study to evaluate the efficacy of lapatinib in eliminating HER2-positive tumor cells circulating in peripheral blood of women with metastatic breast cancer. This is an ASCO Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results